Curia Expands Albuquerque Facility for Sterile Drug Manufacturing
Albuquerque, New Mexico, September 3, 2026 Curia Global, Inc., a global contract research, development and manufacturing organization, has announced...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Albuquerque, New Mexico, September 3, 2026 Curia Global, Inc., a global contract research, development and manufacturing organization, has announced...
Edmonton, Alberta, Canada, September 2, 2026 Aurora Cannabis Inc., a global medical cannabis company, has urged its shareholders to...
Melbourne, Australia and Indianapolis, Indiana, U.S. | August 20, 2026 Telix Pharmaceuticals reported strong first-half 2026 performance, highlighting continued...
Chicago, Illinois, August 18, 2026 VectorBuilder and Lir Therapeutics have announced a strategic collaboration to advance adeno-associated virus (AAV)...
San Diego, California, August 5, 2026 NueCell Bio has officially launched as a specialized cell therapy science and development...
HAVERHILL, United Kingdom, July 6, 2026 Codis announced an agreement to acquire Catalent Pharma Solutions’ Nottingham, UK facility, a...
HOUSTON, June 16, 2026 FibroBiologics announced that the first patients have been dosed in its ongoing Phase 1/2 clinical...
VANCOUVER, British Columbia, June 16, 2026 Optimi Health Corp. has announced the commercial production of two new standardized microdose...
PRINCETON, N.J., June 1, 2026 Made Scientific has been selected as the manufacturing partner for Columbia University’s NOVAKnee program,...
HEIDELBERG, Germany and CHIBA, Japan, May 26, 2026 HEIDELBERG, Germany and CHIBA, Japan, May 26, 2026 — AGC Biologics...
